A phase Ib study to assess safety and tolerability and neutralising activity of CL184 in healthy volunteers

Trial Profile

A phase Ib study to assess safety and tolerability and neutralising activity of CL184 in healthy volunteers

Completed
Phase of Trial: Phase I

Latest Information Update: 30 Nov 2007

At a glance

  • Drugs Foravirumab; Rabies vaccine
  • Indications Rabies
  • Focus Adverse reactions
  • Sponsors Crucell
  • Most Recent Events

    • 14 Nov 2007 The results of this study will be presented on November 30, 2007 at the Joint International Tropical Medicine Meeting 2007 in Bangkok, Thailand.
    • 11 Apr 2007 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top